# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-25-003264
Filing Date
2025-09-08
Accepted
2025-09-08 06:03:02
Documents
6
Period of Report
2025-09-08

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 6-K | zk2533762.htm | 6-K | 12438
2 | EXHIBIT 99.1 | exhibit_99-1.htm | EX-99.1 | 5591186
3 | EXHIBIT 99.2 | exhibit_99-2.htm | EX-99.2 | 17298
4 | EXHIBIT 99.3 | exhibit_99-3.htm | EX-99.3 | 22653
5 | EXHIBIT 99.4 | exhibit_99-4.htm | EX-99.4 | 21078
6 |  | image00001.jpg | GRAPHIC | 352803
| Complete submission text file | 0001178913-25-003264.txt |  | 6151686

Mailing Address IDA BUSINESS PARK BRAY WICKLOW Ireland
Business Address IDA BUSINESS PARK BRAY WICKLOW Ireland 01135312955111
TRINITY BIOTECH PLC (Filer) CIK: 0000888721 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-22320 | Film No.: 251298418
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)